Jared Gollob

Insider Reports History

Entity
Individual
Location
C/O Kymera Therapeutics, Inc., 200 Arsenal Yards, Suite 230, Watertown, MA
Signature
/s/ Bruce Jacobs, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jared Gollob:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Kymera Therapeutics, Inc. Chief Medical Officer Common Stock 95.5K $4.4M $46.10 Jul 16, 2024 Direct
Kymera Therapeutics, Inc. Chief Medical Officer Stock Option (Right to Buy) 22.9K Jul 16, 2024 Direct

Insider Reports Filed by Jared Gollob

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KYMR Kymera Therapeutics, Inc. Jul 15, 2024 7 -$1.72M 4 Jul 16, 2024 Chief Medical Officer
KYMR Kymera Therapeutics, Inc. Mar 1, 2024 5 -$140K 4 Mar 4, 2024 Chief Medical Officer
KYMR Kymera Therapeutics, Inc. Feb 27, 2024 3 -$17.2K 4 Feb 29, 2024 Chief Medical Officer
KYMR Kymera Therapeutics, Inc. Feb 9, 2024 4 -$1.54M 4 Feb 9, 2024 Chief Medical Officer
KYMR Kymera Therapeutics, Inc. Mar 1, 2023 4 -$40.2K 4 Mar 3, 2023 Chief Medical Officer
KYMR Kymera Therapeutics, Inc. May 4, 2022 4 $33.7K 4 May 4, 2022 Chief Medical Officer
KYMR Kymera Therapeutics, Inc. Mar 1, 2022 2 $0 4 Mar 3, 2022 Chief Medical Officer
KYMR Kymera Therapeutics, Inc. Nov 1, 2021 13 -$3.51M 4 Nov 2, 2021 Chief Medical Officer